Funding Opportunity Announcements (FOAs)
This program is part of the NIH HEAL Initiative.
Notices of additional receipt date for FOAs listed below:
HEAL Initiative: Translational Development of Devices to Treat Pain (U18 Clinical Trial Not Allowed)
HEAL Initiative: Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional)
HEAL Initiative Translational Devices to Treat Pain (U44 Clinical Trial Optional)
HEAL Initiative: Clinical Devices to Treat Pain (UH3 Clinical Trial Optional)
HEAL Initiative: Stimulating Peripheral Activity to Relieve Conditions (SPARC): Anatomical and Functional Mapping of Pain-Related Visceral Organ Neural Circuitry (U01 Clinical Trial Optional)
Three webinars were held in December 2018 that introduced the audience to the funding opportunity announcements (FOAs), all seeking to develop medical devices to treat pain. These FOAs support different degrees of technological maturity. All focus on approaches that target the nervous system to provide therapeutic, rehabilitative, or diagnostic capability.
Click here to download webinar slides.